Applicant, as named in the Orange Book
Aaa Usa Inc
Next listed expiry: Lutathera on 25 Jan 2039. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Ingredient | Earliest generic entry | Basis |
|---|
| Lutathera NDA 208700 lutetium lu-177 dotatate | lutetium lu-177 dotatate | 25 Jan 2039 patent | patent |
Recent events
- Lutathera · First generic approved · ANDA 217060, Lantheus MedicalApproved 21 Sep 2026·Detected 25 Oct 2026
- Lutathera · Generic approved · ANDA 217060, Lantheus MedicalApproved 21 Sep 2026·Detected 25 Oct 2026